Edition:
United Kingdom

People: Pacific Biosciences of California Inc (PACB.OQ)

PACB.OQ on NASDAQ Stock Exchange Global Select Market

5.87USD
9:00pm BST
Change (% chg)

$-0.03 (-0.51%)
Prev Close
$5.90
Open
$5.88
Day's High
$5.90
Day's Low
$5.84
Volume
172,623
Avg. Vol
368,119
52-wk High
$7.84
52-wk Low
$3.33

Hunkapiller, Michael 

Dr. Michael W. Hunkapiller, Ph.D., serves as a Chairman of the Board, President, Chief Executive Officer of Pacific Biosciences of California, Inc. He became our President and Chief Executive Officer in 2012. He is Chairman of our Board of Directors, and has served on our Board of Directors since 2005. Since November 2004, Dr. Hunkapiller has been a General Partner at Alloy Ventures, or Alloy, a venture capital firm. Prior to Alloy, Dr. Hunkapiller spent 21 years at Applied Biosystems Inc. At Applied Biosystems, he held various positions, most recently serving as president and general manager. Dr. Hunkapiller holds a Ph.D. in Chemical Biology from the California Institute of Technology and a B.S. in Chemistry from Oklahoma Baptist University. We believe that Dr. Hunkapiller possesses specific attributes that qualify him to serve as a member of our Board of Directors, including his long history with us, as well as his extensive experience at Applied Biosystems.

Basic Compensation

Total Annual Compensation, USD 1,030,000
Restricted Stock Award, USD 427,375
Long-Term Incentive Plans, USD --
All Other, USD 153,490
Fiscal Year Total, USD 1,610,870

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 500,000 245,000.00
Name Fiscal Year Total

Michael Hunkapiller

1,610,870

Susan Barnes

1,125,760

James Phillips

616,991

William Ericson

106,405

Kathy Ordonez

685,758

David Botstein

77,405
As Of  31 Dec 2018